$ Value
$0
Shares
266
Price
$0
Filed
Jun 26
Insider
Name
Hirano Patricia C
Title
SEE REMARKS
CIK
0001766042
Roles
Transaction Details
Transaction Date
2025-06-24
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person September 13, 2024 | Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. | The number of shares beneficially owned has been decreased by 10,000 shares pursuant to an internal review of the Reporting Person's holdings. | All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Filing Info
Hirano Patricia C's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-01 | SLNO | ▼ | $317K |
| 2025-06-24 | SLNO | M | $12K |
| 2025-06-24 | SLNO | ▼ | $22K |
| 2025-06-24 | SLNO | M | $0 |
Other Insiders at SLNO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Manning Meredith
Chief Commercial Officer
|
— | $229K | 2026-03-27 |
|
Huang Michael F.
Sr. VP of Clinical Development
|
— | $200K | 2026-03-27 |